APO Health Adds Exclusive Mail Sanitation System to Product Line.Business Editors & Health/Medical Writers BIOWIRE2K OCEANSIDE, N.Y.--(BW HealthWire)--Nov. 8, 2001 APO Health (OTCBB:APOA APOA - Albuquerque Police Officers Association APOA - Apolipoprotein A) is pleased to introduce a new system designed to help protect employees from the transmission of Anthrax and other bacterial biohazards 1. A biological agent, such as a virus or a condition that constitutes a threat to humans, especially in biological research or experimentation. 2. The potential danger or harm from exposure to such an agent or condition. Ready for immediate shipment, the Mail-Klenz(TM) system is targeted to small and medium sized corporations that want to ensure the safety of its employees who deal with mail. First of its kind, the Mail-Klenz(TM) system includes a sterilizing unit, high filtration face masks, gloves, isolation pouches, and monthly testing strips. APO Health offers three different systems and a custom unit to accommodate different amounts of mail, ranging from $1000 to $30,000. According to the United States Postal Service, since September 11 it has delivered about 30 billion pieces of mail, or about five pieces for each person on earth. More than 90% of that mail originates with businesses. "We feel there is an immediate need in the commercial market for an easy to use, effective, and economical solution to address this problem. Having an internal sterilization system will help ease the minds of everyone involved," said Dr. Jan Stahl, CEO of APO Health. "The system sterilizes 1. to render sterile; to free from microorganisms. 2. to render incapable of reproduction. ster·il·ize (st r the entire envelope including its contents in under an hour. It is easy to install and fits into the typical mailroom." About APO Health APO Health is a multi-faceted distributor of medical, dental and veterinary supplies. These products include protective garments such as disposable isolation gowns, facemasks and gauzes as well as latex gloves, needles, syringes, pharmaceuticals, instruments, and health and beauty aids. This press release contains forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties. A number of important factors could cause the Company's actual results, performance of achievements for fiscal 2001 and beyond to differ materially from that expressed in such forward-looking statements. These factors are set forth in the Company's filings with the Securities and Exchange Commission and include, without limitation, material chances in economic conditions, competition in the Company's industry, operating losses, uncertainties relating to the developing market for new media, changing technologies, seasonality, ability to collect amounts owed to the Company, failure to accurately estimate the time and resources necessary for the performance of services, ability to maintain and expand name recognition, the Company's dependence on key clients and projects and key personnel, costs and uncertainties relating to closing offices, potential adverse effects of litigation, and the ability of the Company to maintain the listing on the Over The Counter Bulletin Board stock exchange or another principal trading exchange. |
|
||||||||||||||

r
Printer friendly
Cite/link
Email
Feedback
Reader Opinion